K-ras codon 12 mutations detected with enriched PCR method in operable non-small cell lung cancer
Kovalchuk, O.; Chyczewska, E.; Niklinska, W.; Niklinski, J.; Naumnik, W.; Chyczewski, L.
Folia Histochemica et Cytobiologica 39(Suppl 2): 68-69
2001
ISSN/ISBN: 0239-8508 PMID: 11820632 Document Number: 537591
Activated point mutations of the K-ras gene are one of the most common genetic alterations found in human malignancies, including lung cancer, and are largely limited to adenocarcinomas. Using a highly sensitive assay for codon 12 K-ras mutation detection, called enriched PCR, we investigated 130 radically resected stage I-IIIa non-small cell lung cancer (NSCLC). There were statistically less positive results for squamous cell carcinoma (1.3%) than for adenocarcinoma (42.4%) and large cell carcinoma (27.8%). No statistically significant association between results of K-ras mutations and TNM stage of disease was found. In stage I of adenocarcinoma patients the incidence of K-ras mutations was similar to that in stage II or IIIa (40%, 42.9% and 42.9%, respectively). The results of our study showed that K-ras mutations might play an important role in pathogenesis of pulmonary adenocarcinoma due to its high prevalence in the operable tumours.